# Cepheid Announces FDA Approval of Xpert Hemorrhagic Fever Panel

By Riza Dagoc

Canonical URL: https://www.tokenpost.com/news/regulation/48146
Published: 2026-11-04T02:05:27.000Z
Updated: 2026-11-04T02:05:27.000Z
Section: Regulation

> The Danaher subsidiary’s PCR test is designed to detect several hemorrhagic fever viruses from one sample.

Cepheid announced Tuesday, Nov. 3, that the U.S. Food and Drug Administration (FDA) approved its Xpert Hemorrhagic Fever Panel. The product is a PCR test designed to detect multiple hemorrhagic fever viruses from one sample.

Cepheid is a subsidiary of Danaher.